Nearly half of people who suffer a traumatic brain injury (TBI) develop depressive symptoms within a year. When depression accompanies TBI, patients often face slower recovery, larger declines in cognitive function, greater disability, increased suicide risk and broader social and sexual difficulties. Because symptoms of TBI and depression overlap and vary widely, diagnosing depression after brain injury can be challenging. Researchers at the Center for BrainHealth at The University of Texas at Dallas have identified a promising brain-based marker tied to the amygdala that may help distinguish depressive subtypes and support more targeted treatment.
Published in Frontiers in Neurology: Neurotrauma, the study shows that people with chronic TBI and comorbid depressive symptoms display altered functional connectivity between the amygdala—the brain’s emotional processing center—and multiple cortical and subcortical networks, compared with those who show minimal depressive symptoms. The research also found distinct connectivity patterns associated with different depressive symptom profiles: cognitive symptoms (negative thought patterns, guilt, worthlessness and suicidal thinking) versus affective symptoms (low mood, crying, loss of interest and anhedonia).
“Separating symptoms caused by traumatic brain injury from those caused by depression is often difficult in clinical practice,” said Kihwan Han, Ph.D., lead author and postdoctoral research associate at the Center for BrainHealth. “Our findings on altered amygdala connectivity offer an objective measure that could help clinicians identify depression subtypes after TBI and design individualized treatment plans.”
Study participants included 54 civilians and veterans with chronic TBI, subdivided into 31 individuals with mild to severe depressive symptoms and 23 with minimal depressive symptoms. All participants were at least six months post-injury, with an average time since injury of about eight years. Ages ranged from 20 to 60. The team used resting-state functional MRI to examine brain network connectivity and assessed depressive symptoms with the Beck Depression Inventory-II alongside standard neuropsychological testing. Participants scored between 5 and 7 on the 8-point Extended Glasgow Outcome Scale, reflecting lower moderate disability to lower good recovery. Primary causes of injury included blasts, blunt force trauma, falls, sports impacts, vehicle accidents, or combinations of these mechanisms. None reported significant neurological or psychiatric diagnoses or depressive symptoms prior to their injury.
Overall, individuals with depressive symptoms after TBI showed increased amygdala connectivity with several brain regions spanning salience, somatomotor, dorsal attention and visual networks. However, the pattern of altered connectivity varied by symptom subtype. Those with predominantly cognitive depressive symptoms exhibited reduced amygdala connectivity with prefrontal areas involved in the default mode and cognitive control networks—areas linked to self-referential thought and executive regulation. In contrast, participants with mainly affective symptoms showed reduced amygdala connectivity with regions of the salience network (including the insula), attention networks (such as the parietal lobules) and visual processing areas.
These dissociable connectivity patterns are important because they point to specific neural circuits that may underlie different manifestations of depression after TBI. Identifying such biomarkers could improve diagnostic accuracy, guide psychiatric and cognitive rehabilitation strategies, and support personalized interventions such as targeted cognitive training or neuromodulation.
This study is part of a broader research program led by principal investigator Daniel Krawczyk, Ph.D., associate professor of cognitive neuroscience and cognitive psychology at the Center for BrainHealth. Supported by the U.S. Department of Defense and the Meadows Foundation, the larger project evaluates strategy-based cognitive training designed for veterans and civilians with traumatic brain injury.
“Our preliminary results are encouraging,” said Daniel Krawczyk, who holds the Debbie and Jim Francis Chair at The University of Texas at Dallas. “Participants who completed Center for BrainHealth cognitive training showed notable decreases in depressive and stress-related symptoms. We aim to clarify how behavioral improvements relate to underlying structural and functional brain changes following injury.”
Future work by the research team will investigate whether reductions in depressive and stress-related symptoms following cognitive training correspond with measurable changes in amygdala connectivity. If so, amygdala connectivity could serve both as a diagnostic biomarker and as an objective outcome measure for therapeutic interventions aimed at depression after brain injury.
“Although this research focuses on traumatic brain injury, the implications extend beyond TBI,” said Sandra Bond Chapman, Ph.D., founder and chief director of the Center for BrainHealth. “Mapping how amygdala connectivity relates to mood and cognition could benefit people who live with chronic depression, including those without any history of brain injury.”
Funding: Supported by the U.S. Department of Defense and the Meadows Foundation.
Source: Emily Bywaters, UT Center for BrainHealth.
Original Research: The study “Altered amygdala connectivity in individuals with chronic traumatic brain injury and comorbid depressive symptoms” by Kihwan Han, Sandra B. Chapman and Daniel C. Krawczyk was published in Frontiers in Neurology: Neurotrauma on November 4, 2015 (doi: 10.3389/fneur.2015.00231).
Abstract
Altered amygdala connectivity in individuals with chronic traumatic brain injury and comorbid depressive symptoms
Depression is one of the most common psychiatric conditions among individuals with chronic traumatic brain injury. Network dysfunction is a hallmark of both TBI and depression, yet few studies have examined connectivity-based neuroimaging biomarkers for comorbid depression in TBI. Using resting-state functional MRI, researchers compared amygdala connectivity in chronic TBI participants with comorbid depressive symptoms (N = 31) versus chronic TBI participants with minimal depressive symptoms (N = 23). The group with depressive symptoms showed relative increases in amygdala connectivity across regions within the salience, somatomotor, dorsal attention and visual networks, as well as within limbic–cortical mood-regulating circuits including dorsomedial and dorsolateral prefrontal cortices, thalamus and brainstem. Further analysis revealed spatially distinct correlations between amygdala connectivity and symptom severity for cognitive versus affective depressive subtypes. These observations suggest that amygdala connectivity could serve as a useful neuroimaging biomarker for identifying comorbid depressive symptoms in chronic TBI populations.